HealthCor Management as of Sept. 30, 2019
Portfolio Holdings for HealthCor Management
HealthCor Management holds 50 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biogen Idec (BIIB) | 8.0 | $211M | 907k | 232.82 | |
| Edwards Lifesciences (EW) | 5.2 | $138M | 626k | 219.91 | |
| Neurocrine Biosciences (NBIX) | 5.1 | $135M | 1.5M | 90.11 | |
| Merck & Co (MRK) | 5.0 | $131M | 1.6M | 84.18 | |
| Intuitive Surgical (ISRG) | 4.8 | $127M | 235k | 539.93 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.3 | $115M | 680k | 169.42 | |
| Danaher Corporation (DHR) | 3.8 | $99M | 687k | 144.43 | |
| Zimmer Holdings (ZBH) | 3.8 | $99M | 723k | 137.27 | |
| Baxter International (BAX) | 3.4 | $90M | 1.0M | 87.47 | |
| Madrigal Pharmaceuticals (MDGL) | 3.4 | $89M | 1.0M | 86.22 | |
| UnitedHealth (UNH) | 3.2 | $86M | 394k | 217.32 | |
| Corindus Vascular Robotics I | 3.2 | $86M | 20M | 4.28 | |
| Nevro (NVRO) | 3.1 | $82M | 954k | 85.97 | |
| Laboratory Corp. of America Holdings | 3.0 | $80M | 474k | 168.00 | |
| Bristol Myers Squibb (BMY) | 2.9 | $77M | 1.5M | 50.71 | |
| Horizon Therapeutics | 2.7 | $72M | 2.6M | 27.23 | |
| Abbott Laboratories (ABT) | 2.4 | $63M | 756k | 83.67 | |
| Medtronic (MDT) | 2.2 | $58M | 535k | 108.62 | |
| Change Healthcare | 1.9 | $51M | 4.3M | 12.08 | |
| Hca Holdings (HCA) | 1.9 | $49M | 407k | 120.42 | |
| Charles River Laboratories (CRL) | 1.8 | $48M | 365k | 132.37 | |
| Bluebird Bio (BLUE) | 1.8 | $47M | 507k | 91.82 | |
| Blueprint Medicines (BPMC) | 1.7 | $45M | 609k | 73.47 | |
| Johnson & Johnson (JNJ) | 1.7 | $44M | 344k | 129.38 | |
| Intersect Ent | 1.6 | $43M | 2.5M | 17.01 | |
| Wright Medical Group Nv | 1.6 | $43M | 2.1M | 20.63 | |
| Hologic (HOLX) | 1.6 | $41M | 810k | 50.49 | |
| CONMED Corporation (CNMD) | 1.6 | $41M | 427k | 96.15 | |
| Iqvia Holdings (IQV) | 1.6 | $41M | 274k | 149.38 | |
| Boston Scientific Corporation (BSX) | 1.5 | $39M | 962k | 40.69 | |
| Alcon (ALC) | 1.2 | $33M | 559k | 58.29 | |
| Gilead Sciences (GILD) | 1.2 | $31M | 483k | 63.38 | |
| Haemonetics Corporation (HAE) | 1.0 | $27M | 212k | 126.14 | |
| Qiagen Nv | 0.8 | $20M | 614k | 32.97 | |
| NuVasive | 0.7 | $19M | 301k | 63.38 | |
| Stryker Corporation (SYK) | 0.7 | $19M | 87k | 216.30 | |
| Humana (HUM) | 0.7 | $18M | 70k | 255.67 | |
| Myokardia | 0.6 | $15M | 282k | 52.15 | |
| Viewray (VRAYQ) | 0.5 | $14M | 4.9M | 2.90 | |
| Genmab A/s -sp (GMAB) | 0.5 | $14M | 697k | 20.26 | |
| Select Medical Holdings Corporation (SEM) | 0.5 | $14M | 825k | 16.57 | |
| D Stemline Therapeutics | 0.5 | $13M | 1.2M | 10.41 | |
| Envista Hldgs Corp (NVST) | 0.3 | $8.4M | 300k | 27.88 | |
| RTI Biologics | 0.2 | $6.2M | 2.2M | 2.85 | |
| Clovis Oncology | 0.2 | $5.9M | 1.5M | 3.93 | |
| Zogenix | 0.2 | $5.2M | 131k | 40.04 | |
| Aurinia Pharmaceuticals (AUPH) | 0.2 | $4.4M | 832k | 5.34 | |
| Ngm Biopharmaceuticals | 0.2 | $4.4M | 317k | 13.85 | |
| Personalis Ord (PSNL) | 0.2 | $4.2M | 284k | 14.67 | |
| Polarityte | 0.1 | $2.1M | 636k | 3.23 |
